{
  "meta": {
    "title": "Biochemistry_Rdx_Quiz",
    "url": "https://brainandscalpel.vercel.app/biochemistry-rdx-quiz-74c8fa6a.html",
    "scrapedAt": "2025-11-30T08:52:42.277Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Accumulation of methylmalonic acid due to defective methylmalonyl-CoA mutase activity</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired dTMP synthesis due to inhibition of thymidylate synthase</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of methylene-THF regeneration due to dihydrofolate reductase inhibition</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired purine synthesis due to reduced formyl-THF availability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old strict vegetarian presents with progressive fatigue and tingling in the feet. Labs reveal macrocytic anemia with elevated homocysteine. Serum methylmalonic acid is also elevated. Which of the following best explains the biochemical basis of his neurologic symptoms?</span></p>",
      "unique_key": "Q320608",
      "question_audio": null,
      "question_video": null,
      "map_id": 320608,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Vitamin B12 deficiency impairs two key reactions: methionine synthase (causing homocysteine accumulation and folate trap) and methylmalonyl-CoA mutase (causing methylmalonic acid accumulation). Neurologic deficits in B12 deficiency correlate with<strong> &uarr; methylmalonic acid</strong> (MMA), which is associated with <strong>abnormal myelin fatty-acid composition</strong> and myelin injury.</p><ul><li><strong>Methionine synthase defect</strong> &rarr; functional folate deficiency &rarr; megaloblastic anemia.</li><li><strong>Methylmalonyl-CoA mutase defect</strong> &rarr; &uarr; methylmalonic acid &rarr; defective myelin &rarr; neurologic symptoms.</li><li>Thus, the presence of both anemia and neurologic deficits strongly indicates Vitamin B12 deficiency rather than folate deficiency.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Impaired dTMP synthesis due to inhibition of thymidylate synthase (Option B):</strong> Seen with methotrexate therapy (folate antagonist), not B12 deficiency.</p><p><strong>Failure of methylene-THF regeneration due to dihydrofolate reductase inhibition (Option C):</strong> This is also a drug effect (methotrexate, trimethoprim, pyrimethamine), not a nutritional B12 deficiency.</p><p><strong>Impaired purine synthesis due to reduced formyl-THF availability (Option D):</strong> A feature of folate deficiency, which causes megaloblastic anemia but lacks neurologic symptoms.</p><p><strong>Key Takeaway:</strong></p><p>Neurologic manifestations of vitamin B12 deficiency are due to <strong>methylmalonic acid accumulation</strong>, while megaloblastic anemia arises from the folate trap. Folate deficiency alone does not produce neurologic symptoms.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1 deficiency</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B2 deficiency</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3 deficiency</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6 deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is given a tryptophan load test. Excessive excretion of xanthurenate is observed in the urine. This finding is most diagnostic of which vitamin deficiency?</span></p>",
      "unique_key": "Q320609",
      "question_audio": null,
      "question_video": null,
      "map_id": 320609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Excessive urinary excretion of <strong>xanthurenate after a tryptophan load</strong> is diagnostic of <strong>Vitamin B6 deficiency</strong>. This is because the enzyme <strong>kynureninase</strong> in the kynurenine pathway of tryptophan metabolism requires <strong>pyridoxal phosphate (active Vitamin B6)</strong> as a cofactor.</p><ul><li><strong>Key Points:</strong><ul><li><strong>Tryptophan metabolism:</strong> Occurs via the <strong>kynurenine-anthranilate pathway</strong>.</li><li><strong>Step 1:</strong> Tryptophan is oxidized by <strong>tryptophan 2,3-dioxygenase</strong> to form <strong>N-formylkynurenine</strong>.</li><li><strong>Step 2:</strong> Hydrolyzed to <strong>kynurenine</strong>.</li><li><strong>Step 3:</strong> <strong>Kynureninase (Vitamin B6 dependent)</strong> converts intermediates further in the pathway.</li><li><strong>Deficiency of B6:</strong> Blocks this step &rarr; accumulation of <strong>kynurenine</strong> &rarr; excretion of <strong>xanthurenate</strong> in urine.</li><li>This serves as a <strong>biochemical diagnostic marker</strong> of Vitamin B6 deficiency.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/2E.png\"><p><strong>Explanation of Other Options:</strong></p><p><strong>Vitamin B1 deficiency (Option A):</strong> Leads to impaired oxidative decarboxylation (e.g., pyruvate &rarr; acetyl-CoA) causing beriberi and Wernicke-Korsakoff syndrome, not linked to xanthurenate excretion.</p><p><strong>Vitamin B2 deficiency (Option B):</strong> Impairs FAD/FMN-dependent enzymes, causing angular cheilitis and glossitis, but does not affect the kynurenine pathway.</p><p><strong>Vitamin B3 deficiency (Option C):</strong> Leads to pellagra (dermatitis, diarrhea, dementia). Although tryptophan is a precursor for niacin, its deficiency does not directly cause xanthurenate excretion after a tryptophan load.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-3, D-1</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-1, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following urea cycle enzyme deficiencies with their associated clinical/metabolic disorders:<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/3Q2.png\"></span></p>",
      "unique_key": "Q320610",
      "question_audio": null,
      "question_video": null,
      "map_id": 320610,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The correct matching of enzymes and associated urea cycle disorders is as follows:</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/3E.png\"><ul><li><strong>Carbamoyl phosphate synthetase I deficiency</strong> &rarr; Hyperammonemia type I (rare, autosomal recessive).</li><li><strong>Ornithine transcarbamoylase deficiency</strong> &rarr; Hyperammonemia type II (X-linked, most common).</li><li><strong>Argininosuccinate synthetase deficiency</strong> &rarr; Citrullinemia.</li><li><strong>Argininosuccinate lyase deficiency</strong> &rarr; Argininosuccinic aciduria (features brittle hair, trichorrhexis nodosa).</li><li><strong>Arginase deficiency</strong> &rarr; Hyperargininemia (later onset, spasticity, developmental delay).</li></ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Base Excision Repair (BER)</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch Repair (MMR)</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotide Excision Repair (NER)</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Nonhomologous End-Joining (NHEJ)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A defect in which DNA repair pathway leads to accumulation of post-replicative base-base mismatches and insertion-deletion loops, ultimately predisposing to hereditary nonpolyposis colorectal cancer (HNPCC)?</span></p>",
      "unique_key": "Q320611",
      "question_audio": null,
      "question_video": null,
      "map_id": 320611,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The <strong>mismatch repair (MMR) system</strong> is responsible for correcting errors that escape proofreading during DNA replication, such as base-base mismatches and small insertion/deletion loops.</p><ul><li>MMR proteins recognize distortions in DNA, excise the incorrect strand segment, and resynthesize the correct DNA using the parental strand as a template.</li><li>Defects in MMR genes (MLH1, MSH2, MSH6, PMS2) cause microsatellite instability and underlie <strong>hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)</strong>.</li><li>Other pathways (BER, NER, NHEJ) correct different forms of DNA damage but not post-replicative mismatches.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Base Excision Repair (Option A):</strong> Repairs small, non-bulky base lesions such as deamination (e.g., cytosine &rarr; uracil) or oxidation, not mismatches.</p><p><strong>Nucleotide Excision Repair (Option C):</strong> Removes bulky helix-distorting lesions such as thymine dimers and chemical adducts, not replication mismatches.</p><p><strong>Nonhomologous End-Joining (Option D):</strong> Repairs DNA double-strand breaks by directly ligating DNA ends, with risk of introducing mutations, not for mismatches.</p><p><strong>Key Takeaway:</strong></p><p>Mismatch repair corrects replication-associated mismatches and prevents microsatellite instability. Defects in MMR &rarr; Lynch syndrome (HNPCC).</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">CRISPR-Cas9 nuclease targets DNA cleavage based on protein-DNA sequence recognition only.</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">The CRISPR-C2c2 variant specifically cleaves DNA and is used for genome editing.</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">CRISPR-Cas9 uses RNA-based targeting to direct site-specific DNA cleavage.</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Restriction endonucleases and CRISPR-Cas9 both function through identical mechanisms of recognition.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding the CRISPR-Cas system is correct?</span></p>",
      "unique_key": "Q320612",
      "question_audio": null,
      "question_video": null,
      "map_id": 320612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>CRISPR-Cas9 employs an <strong>RNA guide (guide RNA)</strong> to target complementary DNA sequences, introducing <strong>double-strand breaks</strong> at specific sites. This is the core reason for its precision in <strong>genome editing</strong>.</p><ul><li>This RNA-guided mechanism distinguishes it from classical restriction enzymes, which recognize fixed DNA sequences directly.</li><li>Variants like <strong>C2c2 (now </strong>Cas13) act on RNA, not DNA.</li></ul><p><strong>Overview of CRISPR-Cas9:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/5E.png\"><p><strong>Explanation of Other Options:</strong></p><p><strong>CRISPR-Cas9 nuclease targets DNA cleavage based on protein-DNA sequence recognition only (Option A):</strong> CRISPR-Cas9 does not rely solely on protein-DNA recognition; it requires <strong>RNA-directed targeting</strong>.</p><p><strong>The CRISPR-C2c2 variant specifically cleaves DNA and is used for genome editing (Option B):</strong> CRISPR-C2c2 is RNA-specific, not DNA-cleaving.</p><p><strong>Restriction endonucleases and CRISPR-Cas9 both function through identical mechanisms of recognition (Option D):</strong> Restriction enzymes recognize specific DNA sequences directly, while CRISPR-Cas9 requires RNA guidance, so their mechanisms differ.</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphatase</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphate dehydrogenase</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Galactokinase</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldose reductase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old boy from the Mediterranean region develops acute hemolysis after taking the antimalarial drug primaquine. On investigation, he is found to have reduced glutathione levels in erythrocytes. Which of the following is the most likely underlying enzyme deficiency?</span></p>",
      "unique_key": "Q320613",
      "question_audio": null,
      "question_video": null,
      "map_id": 320613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical presentation of hemolysis after oxidative stress (primaquine ingestion) is classic for <strong>G6PD deficiency</strong>.</p><ul><li>G6PD is the first enzyme of the <strong>pentose phosphate pathway</strong>, generating <strong>NADPH</strong>, which maintains glutathione in its reduced state.</li><li>Deficiency leads to <strong>impaired detoxification of peroxides</strong>, resulting in red cell lysis under oxidative stress.</li><li>The disorder is common in Mediterranean and Afro-Caribbean populations, with variants differing in enzyme stability and activity.</li><li>The Mediterranean variant is more severe, as the enzyme is stable but has very low activity in all erythrocytes.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Glucose-6-phosphatase (Option A):</strong> Deficiency causes von Gierke's disease (glycogen storage disorder type I), not hemolytic anemia.</p><p><strong>Galactokinase (Option C):</strong> Deficiency causes a form of galactosemia leading to cataracts but not hemolysis.</p><p><strong>Aldose reductase (Option D):</strong> Involved in the polyol pathway; excessive activity contributes to diabetic cataracts, not drug-induced hemolysis.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle phosphorylase</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysosomal &alpha;-1,4 and &alpha;-1,6 glucosidase</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphatase</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver phosphorylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-month-old infant presents with severe hypotonia, cardiomegaly, and feeding difficulties. On examination, the child has macroglossia and hepatomegaly. Echocardiography shows hypertrophic cardiomyopathy. Laboratory studies reveal elevated serum creatine kinase. Which of the following enzyme deficiencies is most likely responsible for this presentation?</span></p>",
      "unique_key": "Q320614",
      "question_audio": null,
      "question_video": null,
      "map_id": 320614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>This clinical picture of <strong>cardiomegaly, hypotonia, macroglossia, and early infantile death</strong> is typical of <strong>Pompe disease (GSD II)</strong>.</p><ul><li>Caused by deficiency of <strong>lysosomal &alpha;-1,4 and &alpha;-1,6 glucosidase (acid maltase)</strong>.</li><li>Leads to <strong>accumulation of glycogen in lysosomes</strong>, especially affecting <strong>heart and skeletal muscle</strong>.</li><li>Infantile form presents with <strong>severe hypotonia (\"floppy baby\")</strong>, <strong>feeding difficulties</strong>, <strong>macroglossia</strong>, and <strong>progressive hypertrophic cardiomyopathy</strong>.</li><li>Death usually occurs by <strong>2 years of age</strong> due to <strong>cardiorespiratory failure</strong>.</li><li>Adult-onset variant presents later with <strong>progressive muscle weakness</strong> without severe cardiac involvement.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Muscle phosphorylase (Option A):</strong> Deficiency causes <strong>McArdle disease (GSD V)</strong>, presenting with <strong>exercise intolerance, muscle cramps, and myoglobinuria</strong>, not cardiomegaly.</p><p><strong>Glucose-6-phosphatase (Option C):</strong> Deficiency causes <strong>von Gierke disease (GSD I)</strong>, presenting with <strong>hypoglycemia, lactic acidosis, hyperuricemia, and hepatomegaly</strong>, but no cardiomyopathy.</p><p><strong>Liver phosphorylase (Option D):</strong> Deficiency causes <strong>Hers disease (GSD VI)</strong>, characterized by <strong>hepatomegaly and mild hypoglycemia</strong>, generally with a good prognosis, not fatal infantile cardiomyopathy.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Depletion of &alpha;-ketoglutarate due to increased conversion to glutamate and glutamine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of succinate dehydrogenase by high NADH/NAD<sup>+</sup>ratio</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired transport of citrate into cytosol, limiting fatty acid synthesis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced activity of pyruvate carboxylase due to biotin deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man with advanced liver disease presents with altered mental status and episodes of convulsions. Laboratory evaluation reveals elevated blood ammonia levels. Which of the following best explains how hyperammonemia leads to impaired cerebral energy metabolism in this patient?</span></p>",
      "unique_key": "Q320615",
      "question_audio": null,
      "question_video": null,
      "map_id": 320615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Hyperammonemia impairs TCA cycle function primarily by diverting <strong>&alpha;-ketoglutarate</strong> into glutamate and glutamine synthesis, causing <strong>cataplerosis</strong> of cycle intermediates. This reduces <strong>TCA cycle flux</strong>, leading to impaired ATP generation in neurons, manifesting as <strong>coma and convulsions</strong>.</p><ul><li><strong>Cataplerosis:</strong> Withdrawal of &alpha;-ketoglutarate lowers cycle intermediates.</li><li><strong>Ammonia toxicity:</strong> Ammonia drives conversion of &alpha;-ketoglutarate &rarr; glutamate &rarr; glutamine.</li><li><strong>Energy failure in brain:</strong> Depletion of &alpha;-ketoglutarate prevents oxidative metabolism of acetyl-CoA.</li><li><strong>Additional effect:</strong> Ammonia also inhibits <strong>&alpha;-ketoglutarate dehydrogenase</strong> and possibly <strong>pyruvate dehydrogenase</strong>, further decreasing cycle activity.</li><li>Clinical correlation: This mechanism underlies <strong>hepatic encephalopathy</strong> in chronic liver disease.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Inhibition of succinate dehydrogenase by high NADH/NAD<sup>+</sup> ratio (Option B):</strong> Incorrect, succinate dehydrogenase is inhibited by oxaloacetate, not directly by NADH/NAD<sup>+</sup> imbalance.</p><p><strong>Impaired transport of citrate into cytosol, limiting fatty acid synthesis (Option C):</strong> Incorrect, this affects lipid synthesis but not cerebral energy metabolism in hyperammonemia.</p><p><strong>Reduced activity of pyruvate carboxylase due to biotin deficiency (Option D):</strong> Incorrect, biotin deficiency impairs gluconeogenesis, not ammonia-induced encephalopathy.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Tangier disease</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia (type IIa)</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial LCAT (lecithin:cholesterol acyltransferase) deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old man is evaluated for premature coronary artery disease. He has no history of steatorrhea or malabsorption. Lipid profile shows markedly very low HDL, low LDL, and elevated triglycerides. Family history reveals several relatives with early atherosclerosis. Which of the following disorders best explains this combination of findings?</span></p>",
      "unique_key": "Q320616",
      "question_audio": null,
      "question_video": null,
      "map_id": 320616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The combination of <strong>near-absence of HDL</strong>, <strong>paradoxically low LDL</strong>, and <strong>familial premature atherosclerosis</strong> with <strong>no fat malabsorption </strong>points to a familial <strong>&alpha;-lipoprotein deficiency</strong> such as <strong>Tangier disease</strong>.</p><ul><li><strong>Tangier disease</strong> &rarr; characterized by <strong>very low/near-absent HDL</strong>, often with <strong>low LDL</strong> and a tendency to <strong>hypertriacylglycerolemia</strong>; associated with <strong>accelerated atherosclerosis</strong> in families.</li><li>Absence of <strong>fat malabsorption</strong> and presence of premature atherosclerosis make <strong>abetalipoproteinemia</strong> unlikely (that disorder causes intestinal lipid accumulation and malabsorption).</li><li>The lab pattern (low HDL + low LDL) is distinct from <strong>familial hypercholesterolemia</strong>, which shows markedly <strong>elevated LDL</strong> and high total cholesterol.</li><li><strong>LCAT deficiency</strong> also lowers HDL but is typified by defective HDL esterification and abnormal LDL/X-fractions (with different biochemical signature than the &alpha;-lipoprotein group).</li><li>Two-step reasoning required: (1) recognize <strong>marked HDL deficiency</strong> as the key abnormality, (2) use the <strong>presence/absence of malabsorption</strong> and <strong>LDL level</strong> to distinguish Tangier disease from other low-HDL syndromes.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Abetalipoproteinemia (Option B):</strong> Rare disorder with absent chylomicrons/VLDL/LDL and intestinal malabsorption; presents with fat-soluble vitamin deficiency and steatorrhea - clinical picture differs because our patient has <strong>no malabsorption</strong>.</p><p><strong>Familial hypercholesterolemia (type IIa) (Option C):</strong> Markedly elevated LDL and total cholesterol with tendon xanthomas and early atherosclerosis; does <strong>not</strong> present with very low HDL and low LDL as in this vignette.</p><p><strong>Familial LCAT deficiency (Option D):</strong> Impaired esterification of cholesterol in HDL producing nascent HDL disks and abnormal lipoprotein X; biochemical phenotype and consequences (eg, low cholesteryl esters, lipoprotein X) differ from the familial &alpha;-lipoprotein/Tangier pattern.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">General acid-base catalysis</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Covalent catalysis</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximity/orientation effects</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Metal-ion catalysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A purified enzyme shows the following experimental findings when reacting with substrate S:<br>1.\tRapid formation of a covalently modified enzyme species detected by mass spectrometry.<br>2.\tA transient decrease in the free active-site nucleophile signal.<br>3.\tThe reaction rate is minimally affected by strong buffering of proton donors/acceptors.<br>Which of the following mechanisms best explains these observations?</span></p>",
      "unique_key": "Q320617",
      "question_audio": null,
      "question_video": null,
      "map_id": 320617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The detection of a covalent enzyme-substrate adduct and modification of an active-site nucleophile are strong indicators of covalent catalysis. Minimal pH dependence further supports this mechanism over general acid-base catalysis.</p><ul><li>Covalent catalysis involves the formation of a <strong>transient covalent intermediate</strong> between enzyme and substrate.</li><li>The presence of a reactive <strong>nucleophilic residue</strong> (e.g., serine, cysteine, lysine) is characteristic.</li><li>Mass spectrometry detection of a covalently modified enzyme confirms intermediate formation.</li><li>Minimal effect of proton buffering indicates that <strong>acid-base transfer is not rate limiting</strong>.</li><li>Classic examples include <strong>serine proteases</strong> and other nucleophile-driven catalysis.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>General acid-base catalysis (Option A):</strong> Typically shows strong pH dependence due to reliance on proton donors/acceptors; does not form stable covalent adducts.</p><p><strong>Proximity/orientation effects (Option C):</strong> Facilitate substrate binding and alignment but do not explain formation of a covalent enzyme-substrate intermediate.</p><p><strong>Metal-ion catalysis (Option D):</strong> Involves Lewis acid stabilization and charge shielding by metal cofactors but does not yield covalent enzyme modification.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Deficiency of riboflavin or vitamin B6 impairs niacin metabolism</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">High dietary intake of nicotinamide reduces NAD synthesis</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Overproduction of serotonin in carcinoid syndrome diverts tryptophan metabolism</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Hartnup disease causes defective membrane transport and renal reabsorption of tryptophan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient develops photosensitive dermatitis, diarrhea, and cognitive changes compatible with pellagra despite adequate dietary tryptophan intake. Intestinal absorption and renal handling of amino acids are normal (no neutral aminoaciduria). The patient has episodic flushing, diarrhea, and wheezing, and urine shows markedly elevated 5-HIAA. Which of the following best explains these findings?</span></p>",
      "unique_key": "Q320618",
      "question_audio": null,
      "question_video": null,
      "map_id": 320618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>In carcinoid syndrome, excessive conversion of <strong>tryptophan &rarr; serotonin</strong> (biomarker: <strong>&uarr; urinary 5-HIAA</strong>) <strong>diverts tryptophan away from the kynurenine pathway</strong>, reducing endogenous <strong>niacin (NAD/NADP) synthesis</strong>. Thus, pellagra can occur <strong>despite adequate dietary tryptophan</strong> and <strong>normal absorption/renal reabsorption</strong>. Niacin is partially \"vitamin-like\" because ~<strong>60 mg tryptophan &asymp; 1 mg niacin equivalent</strong>; diversion of tryptophan lowers this endogenous contribution and precipitates pellagroid features.</p><p><strong>Explanation of Other Options:</strong></p><p><strong>Deficiency of riboflavin or vitamin B6 impairs niacin metabolism (Option A):</strong> Can reduce tryptophan&rarr;niacin conversion, but the stem indicates <strong>no transport defect</strong> and provides a <strong>diversion clue (&uarr;5-HIAA)</strong>, favoring carcinoid over cofactor deficiency.</p><p><strong>High dietary intake of nicotinamide reduces NAD synthesis (Option B):</strong> Excess nicotinamide may cause flushing or hepatotoxicity; it <strong>does not</strong> decrease NAD synthesis to cause pellagra.</p><p><strong>Hartnup disease causes defective membrane transport and renal reabsorption of tryptophan (Option D):</strong> Produces <strong>neutral aminoaciduria</strong> with impaired intestinal/renal transport; the stem specifies <strong>normal transport</strong> and <strong>no aminoaciduria</strong>, making this unlikely.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Exclusive utilization of glucose as the major fuel source</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete oxidation of fatty acids with no contribution from amino acids</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed fuel oxidation involving protein metabolism in addition to carbohydrates and fats</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of ethanol to acetyl-CoA as the predominant metabolic pathway</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A researcher is studying the energy metabolism of a subject maintained on a high-protein diet. Indirect calorimetry reveals an RQ of approximately 0.8. Which of the following best explains this observation?</span></p>",
      "unique_key": "Q320619",
      "question_audio": null,
      "question_video": null,
      "map_id": 320619,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The RQ value provides insight into the mixture of substrates being oxidized. An RQ of ~0.8 is characteristic of <strong>protein oxidation</strong> or mixed substrate utilization, not pure carbohydrate (RQ = 1.0) or fat (RQ = 0.7).</p><ul><li>Protein metabolism generates both CO<sub>2</sub> and consumes O<sub>2</sub>, but the ratio is lower than carbohydrate and higher than fat, hence the intermediate RQ.</li><li>Mixed diets, especially protein-rich ones, shift the RQ toward 0.8.</li><li>This is why indirect calorimetry is useful in distinguishing substrate contributions to metabolism.</li><li><strong>Carbohydrate oxidation (RQ = 1.0):</strong> Equal CO<sub>2</sub>/O<sub>2</sub> ratio</li><li><strong>Fat oxidation (RQ = 0.7):</strong> More O<sub>2</sub> consumed relative to CO<sub>2</sub> produced</li><li><strong>Protein oxidation (RQ &asymp; 0.8):</strong> Intermediate value due to mixed oxidative processes</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Exclusive utilization of glucose (Option A):</strong> Incorrect, as glucose yields an RQ of exactly 1.0, not 0.8.</p><p><strong>Complete oxidation of fatty acids (Option B):</strong> Incorrect, as fatty acid metabolism produces an RQ near 0.7.</p><p><strong>Conversion of ethanol to acetyl-CoA (Option D):</strong> Incorrect, as ethanol metabolism yields an RQ closer to 0.66, lower than 0.8.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">p-Hydroxyphenylpyruvate dioxygenase</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine aminotransferase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisate 1,2-dioxygenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old man presents with progressive low-back and knee pain. On examination, bluish-black pigmentation of the ear cartilage and sclera is noted. He reports that his urine darkens when left standing for several hours. Based on this presentation, which enzyme deficiency best explains his condition?</span></p>",
      "unique_key": "Q320620",
      "question_audio": null,
      "question_video": null,
      "map_id": 320620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The clinical triad of <strong>dark urine on standing, ochronosis (bluish-black connective tissue pigmentation), and arthropathy</strong> is diagnostic of <strong>Alkaptonuria</strong>, an autosomal recessive disorder caused by deficiency of <strong>homogentisate 1,2-dioxygenase</strong>. </p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/13E.png\"><ul><li><strong>Pathogenesis:</strong> Block in conversion of <strong>homogentisate &rarr; maleylacetoacetate</strong>, leading to homogentisic acid accumulation.</li><li><strong>Clinical features:</strong> Ochronosis of cartilage, sclera, and skin; degenerative arthritis; progressive joint and spine involvement.</li><li><strong>Historical note:</strong> One of the four classical \"inborn errors of metabolism\" described by Garrod.</li><li><strong>Complications:</strong> Arthritis often appears in adulthood due to long-term deposition of pigment in connective tissue.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Phenylalanine hydroxylase (Option A):</strong> Deficiency causes <strong>phenylketonuria (PKU)</strong> with intellectual disability and hypopigmentation, not ochronosis.</p><p><strong>p-Hydroxyphenylpyruvate dioxygenase (Option B):</strong> Deficiency blocks conversion of p-hydroxyphenylpyruvate to homogentisate, causing <strong>neonatal tyrosinemia</strong>, not urine darkening.</p><p><strong>Tyrosine aminotransferase (Option C):</strong> Deficiency results in <strong>Tyrosinemia type II (Richner-Hanhart syndrome)</strong> with keratitis and skin lesions, not ochronosis.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisate oxidase</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Isovaleryl-CoA dehydrogenase</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched-chain &alpha;-ketoacid dehydrogenase complex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-day-old neonate presents with poor feeding, recurrent vomiting, irritability, and progressive lethargy. Examination shows hypotonia with intermittent abnormal movements. The parents report that the infant's urine has a sweet \"maple-syrup/burnt sugar\" odor. Which enzyme complex is deficient, impairing the oxidative decarboxylation of branched-chain &alpha;-ketoacids derived from leucine, isoleucine, and valine?</span></p>",
      "unique_key": "Q320621",
      "question_audio": null,
      "question_video": null,
      "map_id": 320621,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>This neonate has <strong>Maple Syrup Urine Disease (MSUD)</strong>, an inborn error of metabolism affecting <strong>branched-chain amino acid (BCAA) catabolism</strong>.</li><li>The impaired reaction is the <strong>oxidative decarboxylation of branched-chain &alpha;-ketoacids</strong> (from leucine, isoleucine, valine) by the <strong>branched-chain &alpha;-ketoacid dehydrogenase complex (BCKDC)</strong>.</li><li><strong>Key clinical clues:</strong><ul><li><strong>Neonatal onset</strong> with feeding difficulty, vomiting, lethargy</li><li><strong>Neurologic dysfunction</strong> (hypotonia, abnormal movements, seizures may occur)</li><li><strong>Urine with maple-syrup/burnt-sugar odor</strong></li></ul></li><li><strong>Biochemical defect:</strong><ul><li><strong>Accumulation</strong> of BCAAs (<strong>leucine, isoleucine, valine</strong>) and their <strong>&alpha;-ketoacids</strong> due to defective BCKDC.</li></ul></li><li><strong>Consequence:</strong><ul><li><strong>Ketoacidosis</strong>, <strong>neurotoxicity</strong> (notably from high <strong>leucine</strong>), <strong>cerebral edema</strong>, and <strong>developmental delay</strong> if untreated.</li></ul></li><li><strong>Genetics:</strong><ul><li>Multiple subtypes (Type IA, IB, II, III) depending on mutation in BCKDC components (<strong>E1&alpha;, E1&beta;, E2, E3</strong>).</li></ul></li><li><strong>Additional high-yield notes (added):</strong><ul><li>Newborn screening may show elevated <strong>alloisoleucine</strong> (diagnostic marker).</li><li><strong>Management:</strong> Prompt protein restriction of BCAAs, careful <strong>leucine</strong> control, <strong>thiamine</strong> (B1) trial in thiamine-responsive variants, and <strong>dialysis</strong> for severe hyperleucinemia.</li></ul></li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Phenylalanine hydroxylase (Option A):</strong> Deficient in <strong>phenylketonuria (PKU)</strong> with &uarr; phenylalanine and neurotoxicity; <strong>unrelated to BCAA oxidative decarboxylation</strong>.</p><p><strong>Homogentisate oxidase (Option B):</strong> Deficient in <strong>alkaptonuria</strong> with dark urine on standing and <strong>ochronosis</strong>, not neonatal sweet-smelling urine or BCAA accumulation.</p><p><strong>Isovaleryl-CoA dehydrogenase (Option C):</strong> Defective in <strong>isovaleric acidemia</strong>, causing <strong>\"sweaty feet\"</strong> odor from isovaleric acid; does not cause across-the-board BCAA and &alpha;-ketoacid elevations typical of MSUD.</p><p><strong>Key Takeaway:</strong></p><p><strong>Sweet-smelling urine + neonatal encephalopathy = MSUD</strong> &rarr; defect in <strong>BCKDC</strong> (oxidative decarboxylation step of BCAA catabolism), with <strong>leucine-driven neurotoxicity</strong> and need for <strong>urgent metabolic management</strong>.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate carboxylase (biotin-dependent carboxylation of pyruvate to oxaloacetate)</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Succinate thiokinase (succinyl-CoA synthetase; conversion of succinyl-CoA to succinate)</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Malate dehydrogenase (mitochondrial reduction of oxaloacetate to malate)</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;-oxidation of fatty-acyl-CoA (providing ATP and NADH for gluconeogenesis)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During hepatic gluconeogenesis, the conversion of oxaloacetate to phosphoenolpyruvate (PEP) requires GTP. Which of the following reactions provides this GTP in the liver?</span></p>",
      "unique_key": "Q320622",
      "question_audio": null,
      "question_video": null,
      "map_id": 320622,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The oxaloacetate &rarr; phosphoenolpyruvate (PEP) step in gluconeogenesis is catalyzed by <strong>PEP carboxykinase</strong>. This requires GTP as the phosphate donor.</p><ul><li>In the <strong>liver and kidney</strong>, this GTP is generated <strong>within the citric acid cycle by succinate thiokinase (succinyl-CoA synthetase)</strong>, which produces GTP (instead of ATP as in other tissues) during the conversion of succinyl-CoA to succinate.</li><li>This links the <strong>TCA cycle</strong> to <strong>gluconeogenesis</strong>, ensuring sufficient GTP supply for PEP formation.</li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Pyruvate carboxylase (Option A):</strong> Catalyzes the ATP-dependent carboxylation of pyruvate to oxaloacetate using biotin as coenzyme. It consumes ATP, not GTP.</p><p><strong>Malate dehydrogenase (Option C):</strong> Involved in the malate shuttle (OAA &harr; malate), crucial for transport across mitochondrial membranes, but does not generate GTP.</p><p><strong>&beta;-oxidation of fatty-acyl-CoA (Option D):</strong> Provides ATP and NADH to fuel gluconeogenesis but not GTP directly required by PEP carboxykinase.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2 correct</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 3 correct</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 4 correct</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2, 3, and 4 correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding McArdle Disease (Glycogen Storage Disease Type V) is/are correct?<br>1.\tIt is caused by a deficiency of the enzyme muscle phosphorylase (PYGM gene defect).<br>2.\tAffected individuals have poor exercise tolerance with abnormally low blood lactate after exercise.<br>3.\tIt commonly presents with hepatomegaly and fasting hypoglycemia<br>4.\tMuscle glycogen content is typically abnormally elevated (2.5-4%).</span></p>",
      "unique_key": "Q320623",
      "question_audio": null,
      "question_video": null,
      "map_id": 320623,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>McArdle Disease (Type V GSD) is due to <strong>deficiency of muscle glycogen phosphorylase (PYGM gene defect)</strong>.</p><ul><li><strong>Key Features:</strong><ul><li><strong>Muscle glycogen phosphorylase deficiency &rarr; impaired glycogenolysis in muscle.</strong></li><li>Leads to <strong>exercise intolerance, muscle cramps, myoglobinuria in severe cases</strong>.</li><li><strong>Blood lactate fails to rise after exercise</strong> because glycogen breakdown is blocked.</li><li><strong>Muscle glycogen content is increased (2.5-4%)</strong>.</li><li><strong>No hypoglycemia or hepatomegaly</strong> since the liver enzyme is unaffected.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/16E.png\">",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate kinase deficiency &rarr; reduced ATP production &rarr; impaired membrane ion pumps &rarr; hemolysis under stress</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Catalase deficiency &rarr; accumulation of hydrogen peroxide &rarr; oxidative hemoglobin damage  &rarr; hemolysis</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexokinase deficiency &rarr; decreased glycolysis &rarr; reduced NADH &rarr; impaired hemoglobin maintenance  &rarr; hemolysis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose-6-phosphate dehydrogenase deficiency &rarr; impaired NADPH generation &rarr; inability to regenerate reduced glutathione  &rarr; hemoglobin oxidation and oxidative hemolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy of Mediterranean ancestry presents with sudden pallor and dark urine 48 hours after eating broad beans. Examination shows jaundice and mild splenomegaly. Laboratory findings reveal hemolytic anemia with Heinz bodies on peripheral smear and elevated indirect bilirubin. Which of the following best explains the underlying biochemical defect?</span></p>",
      "unique_key": "Q320624",
      "question_audio": null,
      "question_video": null,
      "map_id": 320624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The oxidative phase of the pentose phosphate pathway requires glucose-6-phosphate dehydrogenase (G6PD) to generate NADPH. NADPH is essential for maintaining glutathione in its reduced state, protecting erythrocytes from oxidative injury. In G6PD deficiency, oxidative stress (e.g., fava beans, drugs, infection) leads to hemoglobin oxidation, Heinz body formation, and acute hemolysis.</p><ul><li><strong>Biochemical Role of G6PD</strong><ul><li>First enzyme in the oxidative phase of the pentose phosphate pathway</li><li>Catalyzes oxidation of glucose-6-phosphate &rarr; 6-phosphogluconolactone</li><li>Produces <strong>NADPH</strong>, critical for antioxidant defense</li></ul></li><li><strong>Clinical Relevance of NADPH</strong><ul><li>Maintains <strong>glutathione in reduced form</strong> (GSH)</li><li>Detoxifies hydrogen peroxide and reactive oxygen species in RBCs</li><li>Lack of NADPH &rarr; oxidative denaturation of Hb &rarr; Heinz bodies &rarr; membrane damage &rarr; hemolysis</li></ul></li><li><strong>Triggers of Hemolysis in G6PD Deficiency</strong><ul><li>Fava beans (vicine, divicine)</li><li>Antimalarials (primaquine), sulfa drugs, infections</li><li>Lead to sudden intravascular hemolysis</li></ul></li><li><strong>Epidemiology</strong><ul><li>X-linked inheritance</li><li>High prevalence in Mediterranean, African, and Asian populations</li><li>Persistence linked to <strong>protection against malaria</strong></li></ul></li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Pyruvate kinase deficiency (Option A):</strong> Leads to ATP depletion and chronic hemolysis but does not cause oxidant-induced hemolysis or Heinz body formation.</p><p><strong>Catalase deficiency (Option B):</strong> Rare, associated with hydrogen peroxide accumulation, but RBCs primarily rely on glutathione peroxidase rather than catalase for detoxification.</p><p><strong>Hexokinase deficiency (Option C):</strong> Decreases glycolytic flux and NADH but does not explain the episodic oxidant-triggered hemolysis seen in this case.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Deficiency of Apo C-II leading to inactive lipoprotein lipase</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in Apo E preventing remnant clearance</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in the LDL receptor impairing binding to Apo B-100</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of lecithin:cholesterol acyltransferase (LCAT)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old boy presents with multiple tendon xanthomas and a strong family history of premature coronary artery disease. Laboratory evaluation reveals markedly elevated LDL cholesterol with normal triglycerides. Genetic analysis shows a mutation in a membrane protein involved in lipoprotein clearance. Which of the following best explains the underlying defect in this patient?</span></p>",
      "unique_key": "Q320625",
      "question_audio": null,
      "question_video": null,
      "map_id": 320625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The patient has <strong>familial hypercholesterolemia (FH, Type IIa hyperlipoproteinemia)</strong>, characterized by <strong>defective LDL receptors</strong> or mutations in the ligand-binding domain of <strong>Apo B-100</strong>. This leads to:</p><ul><li><strong>Elevated LDL cholesterol</strong> in plasma.</li><li><strong>Normal triglycerides</strong>, distinguishing it from other dyslipidemias.</li><li><strong>Tendon xanthomas</strong> and <strong>premature atherosclerosis</strong>, with early cardiovascular disease.</li></ul><p><strong>Pathogenesis summary:</strong></p><ul><li>LDL receptor normally mediates uptake of LDL particles into liver and extrahepatic tissues.</li><li>In FH, receptor mutations &rarr; impaired LDL clearance &rarr; LDL accumulation.</li><li>Inheritance is usually <strong>autosomal dominant</strong>.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemRdx11102025/18E.png\"><p><strong>Explanation of Other Options:</strong></p><p><strong>Deficiency of Apo C-II leading to inactive lipoprotein lipase (Option A):</strong> Incorrect. This causes Type I hyperlipoproteinemia with chylomicronemia and pancreatitis, not tendon xanthomas with high LDL.</p><p><strong>Mutation in Apo E preventing remnant clearance (Option B):</strong> Incorrect. Seen in Type III hyperlipoproteinemia, with increased IDL/&beta;-VLDL and palmar xanthomas.</p><p><strong>Absence of lecithin:cholesterol acyltransferase (LCAT) (Option D):</strong> Incorrect. Leads to abnormal reverse cholesterol transport with corneal opacities and anemia, not isolated LDL elevation.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">HSL is activated by insulin through stimulation of phosphodiesterase, which increases cAMP.</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">HSL requires phosphorylation by cAMP-dependent protein kinase for activation, a process enhanced by catecholamines.</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">HSL hydrolyzes circulating lipoprotein triacylglycerols before uptake into extrahepatic tissues.</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">HSL hydrolyzes circulating lipoprotein triacylglycerols before uptake into extrahepatic tissues.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following most accurately explains the regulation of hormone-sensitive lipase (HSL) during adipose tissue lipolysis?</span></p>",
      "unique_key": "Q320626",
      "question_audio": null,
      "question_video": null,
      "map_id": 320626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Hormone-sensitive lipase (HSL) is the key enzyme regulating lipolysis in adipose tissue, activated by phosphorylation via cAMP-dependent protein kinase (PKA), primarily under catecholamine stimulation.</p><ul><li><strong>Activation mechanism:</strong><ul><li>Catecholamines (epinephrine, norepinephrine), ACTH, TSH, GH, and glucagon stimulate <strong>adenylate cyclase &rarr; cAMP &rarr; PKA</strong>, which phosphorylates and activates HSL.</li><li>Insulin exerts an <strong>antilipolytic effect</strong> by activating <strong>phosphodiesterase</strong> (which breaks down cAMP) and <strong>lipase phosphatase</strong> (which dephosphorylates HSL), thus inhibiting its activity.</li></ul></li><li><strong>Perilipin regulation:</strong><ul><li>Perilipin phosphorylation is essential to expose lipid droplets, permitting activated HSL to access stored triacylglycerol.</li></ul></li><li><strong>Substrate specificity:</strong><ul><li>HSL acts on <strong>stored adipose tissue triacylglycerols</strong>, not on circulating lipoproteins (that function is carried out by <strong>lipoprotein lipase</strong>).</li></ul></li><li><strong>Feedback:</strong><ul><li>High FFA concentrations and adenosine inhibit adenylate cyclase, providing negative feedback regulation.</li></ul></li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Activation of HSL by insulin through phosphodiesterase and cAMP (Option A):</strong> Incorrect. Insulin actually inhibits lipolysis by lowering cAMP and activating phosphatases, not by stimulating HSL.</p><p><strong>Hydrolysis of circulating lipoprotein triacylglycerols by HSL (Option C):</strong> Incorrect. This is the function of <strong>lipoprotein lipase</strong>, not hormone-sensitive lipase.</p><p><strong>Activation of HSL when perilipin is dephosphorylated (Option D):</strong> Incorrect. HSL requires <strong>perilipin phosphorylation</strong>, not dephosphorylation, for access to lipid droplets.</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylcholine</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiolipin</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelin</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylinositol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Barth syndrome, an X-linked disorder associated with cardioskeletal myopathy, is due to defective metabolism of which mitochondrial phospholipid?</span></p>",
      "unique_key": "Q320627",
      "question_audio": null,
      "question_video": null,
      "map_id": 320627,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The biochemical hallmark of <strong>Barth syndrome</strong> is defective <strong>cardiolipin metabolism</strong>.</p><ul><li><strong>Cardiolipin:</strong><ul><li>A unique phospholipid located exclusively in the <strong>inner mitochondrial membrane</strong>.</li><li>Essential for mitochondrial oxidative phosphorylation and energy metabolism.</li><li>Altered cardiolipin levels lead to mitochondrial dysfunction, resulting in <strong>cardioskeletal myopathy, neutropenia, and growth retardation</strong> in Barth syndrome.</li><li>Hence, mutation affecting cardiolipin remodeling is the root biochemical defect.</li></ul></li></ul><p><strong>Explanation of Other Options:</strong></p><p><strong>Phosphatidylcholine (Option A):</strong> Major structural phospholipid of membranes and pulmonary surfactant; not implicated in Barth syndrome.</p><p><strong>Sphingomyelin (Option C):</strong> Abundant in myelin sheaths and lipid rafts; defects lead to Niemann-Pick disease, not Barth syndrome.</p><p><strong>Phosphatidylinositol (Option D):</strong> Involved in second messenger generation (DAG, IP<sub>3</sub>); unrelated to Barth syndrome.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}